BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27649671)

  • 1. Dystroglycan induced muscular dystrophies - a review.
    Zhang QZ
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3683-7. PubMed ID: 27649671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycobiology of α-dystroglycan and muscular dystrophy.
    Endo T
    J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
    Martin PT
    Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular overview of the primary dystroglycanopathies.
    Brancaccio A
    J Cell Mol Med; 2019 May; 23(5):3058-3062. PubMed ID: 30838779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation defects in muscular dystrophies.
    Haliloğlu G; Topaloğlu H
    Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dystroglycanopathies: the new disorders of O-linked glycosylation.
    Martin PT
    Semin Pediatr Neurol; 2005 Sep; 12(3):152-8. PubMed ID: 16584074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.
    Munot P; McCrea N; Torelli S; Manzur A; Sewry C; Chambers D; Feng L; Ala P; Zaharieva I; Ragge N; Roper H; Marton T; Cox P; Milev MP; Liang WC; Maruyama S; Nishino I; Sacher M; Phadke R; Muntoni F
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12771. PubMed ID: 34648194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins.
    Nguyen H; Ostendorf AP; Satz JS; Westra S; Ross-Barta SE; Campbell KP; Moore SA
    Acta Neuropathol Commun; 2013 Sep; 1():58. PubMed ID: 24252195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.
    Chong YK; Ma LC; Lo KL; Lee CK; Mak CM; Kan AN; Lam CW
    Eur J Paediatr Neurol; 2014 Jul; 18(4):532-5. PubMed ID: 24657014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E; Blake DJ
    Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomarkers for muscular dystrophy.
    Hewitt JE
    Biochem Soc Trans; 2011 Jan; 39(1):336-9. PubMed ID: 21265799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of expression of dystroglycan may protect the heart.
    Brancaccio A
    Neuromuscul Disord; 2013 Nov; 23(11):867-70. PubMed ID: 23911074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dystroglycan linkage and muscular dystrophy].
    Shimizu T
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Journey into muscular dystrophies caused by abnormal glycosylation.
    Muntoni F
    Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
    Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
    Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.